Drug Shortage Report for MYLAN-BUPROPION XL

Last updated on 2019-06-19 History
Report ID 3941
Drug Identification Number 02382075
Brand name MYLAN-BUPROPION XL
Common or Proper name BUPROPION XL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPROPION HYDROCHLORIDE
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90BT, 500BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-05-18
Actual start date 2018-05-04
Estimated end date 2019-09-30
Actual end date 2019-06-18
Shortage status Resolved
Updated date 2019-06-19
Company comments Manufacturing issues
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v41 2017-12-08 English Compare
v42 2017-12-08 French Compare
v43 2017-12-11 English Compare
v44 2017-12-11 French Compare
v45 2017-12-14 English Compare
v46 2017-12-14 French Compare
v47 2017-12-18 English Compare
v48 2017-12-18 French Compare
v49 2017-12-20 English Compare
v50 2017-12-20 French Compare
v51 2017-12-22 English Compare
v52 2017-12-22 French Compare
v53 2017-12-30 English Compare
v54 2018-01-02 English Compare
v55 2018-01-02 French Compare
v56 2018-01-05 English Compare
v57 2018-01-05 French Compare
v58 2018-01-10 English Compare
v59 2018-01-10 French Compare
v60 2018-01-12 English Compare

Showing 41 to 60 of 127